Related Experiment Video
Updated: Jan 27, 2026
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.7K
ADRB2-Targeting Therapies for Prostate Cancer
George Kulik1,2
1Department of Cancer Biology, Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC 27157, USA. gkulik@wakehealth.edu.
Cancers
|March 16, 2019
Summary
Propranolol may treat prostate cancer by blocking beta-2 adrenergic receptor (ADRB2) signaling. Identifying specific biomarkers is crucial for patient selection to ensure effective treatment and overcome therapy resistance.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Beta-2 adrenergic receptor (ADRB2) signaling is implicated in prostate cancer progression and resistance to therapy.
- Propranolol, a beta-blocker, targets ADRB2 but its efficacy can vary even with active ADRB2 signaling.
- Apoptosis inhibition by ADRB2 activation is a key mechanism in prostate cancer pathophysiology.
Purpose of the Study:
- To analyze ADRB2 signaling within the context of prostate cancer's redundant signaling network.
- To identify biomarkers for selecting patients who will benefit from propranolol therapy.
- To guide clinical trials for ADRB2 antagonist propranolol as a life-extending prostate cancer treatment.
Main Methods:
- Review of existing evidence on ADRB2 signaling and apoptosis in prostate cancer.
- Analysis of signaling pathways that control apoptosis and contribute to therapy resistance.
- Proposal of biomarker classes for patient stratification in clinical trials.
Main Results:
- ADRB2 signaling contributes to prostate cancer by inhibiting apoptosis.
- Redundant signaling pathways in prostate tumors necessitate a comprehensive analysis.
- Biomarker-guided patient selection is essential for effective propranolol therapy.
Conclusions:
- Understanding ADRB2-activated antiapoptotic mechanisms is key to successful propranolol trials.
- Three classes of biomarkers are proposed for selecting patients for propranolol therapy.
- Targeting ADRB2 with propranolol, guided by biomarkers, offers potential for life extension in prostate cancer patients.
Related Concept Videos
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
02:49Cancer Therapies
10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
01:26Group Therapy
417
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
417
01:29Psychodynamic Therapy
549
Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
549
01:24Humanistic Therapy
348
Humanistic therapies emphasize personal growth, self-understanding, and the fulfillment of human potential. Rooted in the belief that individuals inherently strive toward self-actualization, these approaches encourage clients to explore their feelings and experiences in a supportive, nonjudgmental environment. Humanistic therapies differ from psychodynamic approaches by focusing on conscious experiences, present circumstances, and the potential for self-improvement rather than past conflicts...
348